141 related articles for article (PubMed ID: 1826882)
21. Simplified technetium-99m-EC clearance in adults from a single plasma sample.
Kabasakal L; Yapar AF; Ozker K; Alkan E; Atay S; Ozçelik N; Onsel C
J Nucl Med; 1997 Nov; 38(11):1784-6. PubMed ID: 9374355
[TBL] [Abstract][Full Text] [Related]
22. Prediction of renal transplant survival from early postoperative radioisotope studies.
Russell CD; Yang H; Gaston RS; Hudson SL; Diethelm AG; Dubovsky EV
J Nucl Med; 2000 Aug; 41(8):1332-6. PubMed ID: 10945523
[TBL] [Abstract][Full Text] [Related]
23. Estimation of 99Tcm-MAG3 clearance using a single blood sample obtained over a continuous time interval.
Piera C; Ros D; Pavia J; Fuster D; Muxi A
Nucl Med Commun; 1997 Jan; 18(1):60-5. PubMed ID: 9061703
[TBL] [Abstract][Full Text] [Related]
24. A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders.
Müller-Suur R; Bois-Svensson I; Mesko L
J Nucl Med; 1990 Nov; 31(11):1811-7. PubMed ID: 2146371
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the single-injection plasma disappearance of technetium-99m mercaptoacetyltriglycine method for determination of effective renal plasma flow in dogs with normal or abnormal renal function.
Itkin RJ; Krawiec DR; Twardock AR; Gelberg HB; Koritz GD
Am J Vet Res; 1994 Dec; 55(12):1652-9. PubMed ID: 7887506
[TBL] [Abstract][Full Text] [Related]
26. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance in patients with impaired renal function.
Erdil TY; Dede F; Tuglular S; Sen F; Ones T; Farsakoglu Z; Inanir S; Ozener C; Akoglu E; Turoglu T
Nucl Med Commun; 2006 Feb; 27(2):191-6. PubMed ID: 16404234
[TBL] [Abstract][Full Text] [Related]
27. 99Tcm-MAG3 for quantitation of differential renal function.
Llamas-Elvira JM; Martinez-Paredes M; Jimenez-Heffernan A; Sopena R; Requena MJ; Gonzalez FM; Torres M; Mateo A
Nucl Med Commun; 1989 Oct; 10(10):759-64. PubMed ID: 2559380
[TBL] [Abstract][Full Text] [Related]
28. Radionuclide renal studies.
Abdel-Dayem HM; Turoglu HT
Curr Opin Radiol; 1990 Dec; 2(6):834-43. PubMed ID: 2149277
[No Abstract] [Full Text] [Related]
29. (99m)Tc-HEPIDA hepatic clearance as a diagnostic tool: usefulness of a single sample plasma and hepatic clearance of (99m)Tc-HEPIDA for assessment of hepatic parenchyma performance.
Surma MJ; Frieske I; Jencz K; Kuźmierek J
Nucl Med Rev Cent East Eur; 2006; 9(2):125-31. PubMed ID: 17304475
[TBL] [Abstract][Full Text] [Related]
30. [The estimation of effective renal plasma flow (ERPF) based on two compartment analysis using 99mTc-mercaptoacetyltriglycine (99mTc-MAG3)].
Ha-Kawa SK; Suga Y; Satou H; Tanaka Y
Kaku Igaku; 1994 Feb; 31(2):175-81. PubMed ID: 8121073
[TBL] [Abstract][Full Text] [Related]
31. A new principle to normalize plasma concentrations allowing single-sample clearance determinations in both children and adults.
Bubeck B; Piepenburg R; Grethe U; Ehrig B; Hahn K
Eur J Nucl Med; 1992; 19(7):511-6. PubMed ID: 1386574
[TBL] [Abstract][Full Text] [Related]
32. Compartmental analysis of the complete dynamic scan data for scintigraphic determination of effective renal plasma flow.
Dagli MS; Caride VJ; Carpenter S; Zubal IG
J Nucl Med; 1997 Aug; 38(8):1285-90. PubMed ID: 9255169
[TBL] [Abstract][Full Text] [Related]
33. Renal and extrarenal handling of a new imaging compound (99m-Tc-MAG-3) in the rat.
Müller-Suur R; Müller-Suur C
Eur J Nucl Med; 1986; 12(9):438-42. PubMed ID: 2949975
[TBL] [Abstract][Full Text] [Related]
34. Optimization of the uptake method for estimating renal clearance of 99mTc mercaptoacetyltriglycine.
Zhao C; Shuke N; Okizaki A; Yamamoto W; Usui K; Kikuchi K; Kaneko S; Yachiku S; Sasajima T; Aburano T
Nucl Med Commun; 2004 Feb; 25(2):159-66. PubMed ID: 15154706
[TBL] [Abstract][Full Text] [Related]
35. Quantitation of renal function with technetium-99m MAG3.
Russell CD; Thorstad BL; Yester MV; Stutzman M; Dubovsky EV
J Nucl Med; 1988 Dec; 29(12):1931-3. PubMed ID: 2973517
[TBL] [Abstract][Full Text] [Related]
36. Quantification of renal function with a count-based gamma camera method using technetium-99m-MAG3 in children.
Itoh K; Nonomura K; Yamashita T; Kanegae K; Murakumo M; Koyanagi T; Furudate M
J Nucl Med; 1996 Jan; 37(1):71-5. PubMed ID: 8544005
[TBL] [Abstract][Full Text] [Related]
37. Reproducibility of single-sample clearance of 99mTc-mercaptoacetyltriglycine and 131I-orthoiodohippurate.
Russell CD; Dubovsky EV
J Nucl Med; 1999 Jul; 40(7):1122-4. PubMed ID: 10405130
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases.
Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Koyanagi T; Furudate M; Torizuka K
Clin Nucl Med; 1993 May; 18(5):387-93. PubMed ID: 8508572
[TBL] [Abstract][Full Text] [Related]
39. Administered activity optimization in 99mTc-MAG3 renography for adults.
Díaz MP; Aparicio EE; Rizo OD; Díaz RR; Rodríguez CH
J Nucl Med Technol; 2003 Dec; 31(4):216-21. PubMed ID: 14657288
[TBL] [Abstract][Full Text] [Related]
40. Effect of renal maturation on the clearance of technetium-99m mercaptoacetyltriglycine.
Lythgoe MF; Gordon I; Anderson PJ
Eur J Nucl Med; 1994 Dec; 21(12):1333-7. PubMed ID: 7875172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
